SI-BONE, Inc. (SIBN)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$18.50-0.75%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · SIBN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 213.6 | 200.9 | 167.2 | 138.9 | 106.4 | 90.2 | 73.4 | 55.4 | 55.4 |
| Total Revenues | — | — | — | — | — | — | — | 55.4 | 55.4 |
| Cost of Revenues | 43.7 | 41.0 | 35.1 | 29.5 | 15.7 | 10.4 | 8.9 | 6.8 | 4.8 |
| Gross Profit | 169.9 | 159.9 | 132.1 | 109.4 | 90.7 | 79.7 | 64.5 | — | 50.5 |
| Operating Expenses & Income | |||||||||
| R&D Expenses | 18.0 | 17.4 | 16.6 | 15.0 | 13.6 | 12.4 | 9.5 | 7.3 | 5.4 |
| Operating Income | (17.7) | (22.3) | (35.2) | (46.9) | (59.6) | (51.7) | (38.6) | (36.0) | (12.0) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | 2.6 | 3.4 | 3.5 | 2.8 | 5.4 | 6.1 | 4.9 | 5.1 |
| Interest & Investment Income | 5.6 | 6.1 | 7.8 | 6.9 | 1.3 | 0.2 | 1.1 | 2.6 | 0.8 |
| Net Interest Expenses | — | — | — | (3.5) | 1.5 | 5.2 | 5.0 | 2.4 | 4.3 |
| EBT, Incl. Unusual Items | — | — | — | — | — | — | (43.7) | (38.4) | (17.5) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | — | — | 0.0 |
| Net Income | |||||||||
| Net Income | (14.6) | (18.9) | (30.9) | (43.3) | (61.3) | (56.6) | (43.7) | (38.4) | (17.5) |
| Per Share | |||||||||
| Basic EPS | (0.33) | (0.44) | (0.75) | (1.13) | (1.79) | (1.71) | (1.50) | — | — |
| Diluted EPS | (0.33) | (0.44) | (0.75) | (1.13) | (1.79) | (1.71) | (1.50) | — | — |
| Revenue per Share | 4.80 | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Avg Shares | 44.5 | 43.0 | 41.5 | 38.4 | 34.2 | 33.1 | 29.1 | — | — |
| Diluted Weighted Avg Shares | 44.5 | 43.0 | 41.5 | 38.4 | 34.2 | 33.1 | 29.1 | — | — |
| Supplemental | |||||||||
| EBITDA | — | (16.6) | (30.9) | (41.5) | (56.2) | (49.6) | (37.4) | (35.2) | (11.2) |
| EBIT | (17.7) | (22.3) | (35.2) | (46.9) | (59.6) | (51.7) | (38.6) | (36.0) | (12.0) |
| Effective Tax Rate | — | — | — | — | — | — | — | — | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.